1 regulatory T (Treg) cells are considered a sub-lineage of CD4 1 T cells that are protective against autoimmunity due to their essential roles in maintaining immune homeostasis and self-tolerance. However, Treg cells are unstable in vivo in terms of lineage specialization and suppressive function. These unstable Treg cells play roles in the pathogenesis of diseases, which cause safety concerns regarding human Treg cell therapy. In this review, we highlight recent findings that demonstrate the pathogenic conversion of Treg cells in different disease models.
INTRODUCTION
The T cell-mediated immune response is tightly controlled, ensuring the protection of the body while limiting self-harm, which depends on several mechanisms of immune tolerance, including clonal deletion, clonal anergy, immunological ignorance and suppressive T cells. 1 Several types of suppressive T cells have been reported, such as IL-10-producing CD4 
CD28
2 T cells, 6 and Qa-1-restricted CD8 1 T cells. 7 Among these suppressive T cells, CD4 1 T cells in humans and mice. 4, 8 Treg cells generated ex vivo, such as those induced with TGF-b, are termed 'in vitro-induced Treg cells (iTreg)', which can also suppress autoimmune disease in vivo. 9, 10 Treg cells specifically express the transcription factor Foxp3 (forkhead box protein P3) and highly express surface and intracellular markers, including CD25, GITR and CTLA-4, which define the phenotypes and functions of Treg cells. [11] [12] [13] In humans, CD4
1 CD45RA 1 FoxP3 lo and CD45RA 2 FoxP3 hi cells are considered bona fide regulatory T cells because activated T cells can upregulate FOXP3 expression without acquiring a regulatory phenotype. 14 The suppressive functions of Treg cells play crucial roles in the maintenance of immune homeostasis and self-tolerance, as demonstrated by scrufy mice and IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome) patients harboring Foxp3 gene mutations and develop severe autoimmune diseases because of the paucity or dysfunction of Treg cells. 15, 16 Treg cells do not have a unified mechanism of immune suppression. In contrast, they utilize diverse suppressive mechanisms depending on microenvironments and target cells, including inhibitory cytokines (e.g., IL-10, IL-35 and TGF-b), cytolysis, metabolic disruption or the modulation of dendritic cell function. Based on these striking immune suppressive properties of Treg cells, several clinical trials utilizing them to treat autoimmune diseases are currently underway and show promising potential. 17 Recently, increasing evidence has indicated that the lineage specialization and suppressive function of Treg cells are unstable in vivo, as demonstrated by the loss of Foxp3 expression and acquisition of Th cell-like functions, which underscore the safety concerns with regard to human Treg cell therapy. Although the instability of Treg cells may be physiologically required for immune homeostasis (e.g., transient downregulation of Treg cell function favors an effective immune response against pathogen invasion), it should be noted that Treg cell instability can be pathogenic. Indeed, several studies report on the pathogenic cells derived from Treg cells either in mice or in humans. In this review, we highlight the studies that have demonstrated the pathogenic conversion of Treg cells in different disease models.
FUNCTIONS OF TREG CELLS AND HEALTH
Before discussing the pathogenic conversion of Treg cells, it is important to understand the normal functions of Treg cells. Consistent with the severe autoimmune diseases in scurfy mice and IPEX patients, the ablation of Treg cells through germ-line deletion of the Foxp3 gene, conditional deletion of Foxp3 in mature Treg cells, or diphtheria toxin receptor-mediated depletion of Treg cells, leads to severe autoimmunity in mice. [18] [19] [20] In contrast, transferred Treg cells, Foxp3 transgene expression, or bone marrow reconstitution can rescue the scurfy mice, 15, 18, 21 indicating that Treg cells are continuously needed throughout life. Moreover, as a subset of lymphocytes, Treg cells circulate throughout the body and generate locally. Therefore, they are located in different anatomical sites, such as blood, lymphoid organs and diverse tissues (where they stay in different developmental stages and functional statuses), to safeguard the body against autoimmunity. 22 Similarly, the Th2 transcription factor IRF4 is needed for Treg cells to inhibit the Th2-mediated autoimmune response, 23 and other transcription factors such as STAT3 and Bcl-6 are necessary to inhibit Th17-mediated spontaneous colitis and aberrant germinal center responses, respectively. [24] [25] [26] Moreover, Treg cells express tissue-associated transcriptions factor to perform different functions in tissues, such as PPAR-c, the 'master regulator' of adipocyte differentiation and function. 27 PPAR-c-expressing Treg cells selectively accumulate in the visceral adipose tissue of aged mice and acquire adipocyte-like functions, such as taking up lipids. 28 In addition, a recent study showed that a subset of Treg cells could infiltrate injured skeletal muscle and contribute to muscle repair. These muscle-resident Treg cells produce the growth factor Amphiregulin, which aids in the colony-forming efficiency of muscle satellite cells in vitro and improves muscle repair in vivo. 29 30, 31 In contrast, the ablation of Treg cells contributes to Mtb clearance. 32 Moreover, Treg cells can accumulate at tumor sites to inhibit anti-tumor immune responses and facilitate tumor immune evasion. 33 Aside from improper suppressive functions promoting disease progression indirectly, Treg cells have the potential to promote diseases directly by conversion into pathogenic cells, especially in autoimmune diseases. Some unique characteristics make Treg cells potentially pathogenic, including their linage instability, self-skewed T-cell receptor (TCR) repertoire, and atypical functions. These characteristics are discussed below.
Instability of the Treg cell lineage. Foxp3 is indispensable for the development and function of Treg cells. However, increasing evidence indicates that Treg cells can lose Foxp3 expression to generate so-called 'exTreg' cells in vivo, which are associated with external inputs, such as IL-2 depletion, strong TCR engagement with autoantigens, and pro-inflammatory cytokines. [34] [35] [36] The TCR repertoire of exTreg cells substantially overlaps with that of both Treg cells and conventional T cells, which indicates that exTreg cells are heterogeneous and are derived in part from established Treg cells that have lost Foxp3 expression and in part from Foxp3 2 conventional T cells that expressed Foxp3 transiently. 34, 37 Foxp3 expression in Treg cells is maintained intrinsically by a positive feedback loop comprising the CNS2 region in the Foxp3 gene locus, the Cbfb-Runx1 transcription factor, Foxp3 itself, and other factors if any, where the CNS2, Cbfb-Runx1 and Foxp3 binds to each other to form a transcription complex. 19, [38] [39] [40] [41] Treg cells lacking CNS2, Cbfb, or Runx1 cannot maintain stable Foxp3 expression. 38, 39 Similarly, a recent study further highlighting the importance of CNS2 demonstrates that Treg cells are stabilized by the IL-2/STAT5 pathway while destabilized by the IL-4/STAT6 and IL-6/STAT3 pathways through the competitive occupation of CNS2 between STATs. In the absence of CNS2, Treg cells cannot maintain heritable Foxp3 expression either under IL-2-limiting conditions or in the presence of inflammatory cytokines. 42 Another relevant study shows that the NFAT-mediated looping between CNS2 and the Foxp3 promoter is critical for Foxp3 expression in activated Treg cells. 43 These studies indicate that the CNS2-mediated feedback loop is critical for the maintenance of Treg cell lineage stability.
Attenuating the DNA binding activity of Foxp3 potentially breaks the CNS2-Cbfb-Runx1-Foxp3 feedback loop, resulting in Treg cell lineage instability. We developed a luciferase-based reporter system (FOXP3Luc) to monitor the DNA binding activity of Foxp3. Using this reporter for an unbiased screening, we identified that MAPKK kinase COT/Tpl2, and its target MEK1, showed inhibitory effects on the readout of the FOXP3Luc reporter. The inhibition of either COT/Tpl2 or MEK1 favors the stable Foxp3 expression in cultured Treg cells. Importantly, constitutive activation of MEK1 destabilizes Treg cells in vivo. 44 This finding is consistent with our previous study indicating the role of TCR overstimulation by autoantigens in Treg cell instability; BDC2.5 TCR 1 Treg cells or MOG 38-49 -specific Treg cells, which recognize autoantigens of the pancreas and myelin oligodendrocyte glycoprotein in the central nervous system, respectively, are significantly unstable in inflamed sites. 34, 45 Recent studies report that PTEN is essential for maintaining Treg cell stability by limiting phosphoinositide 3-kinase signaling, 46, 47 which also supports the notion that TCR overstimulation destabilizes Treg cells. In addition, the CDK2-mediated Foxp3 degradation and PIM1-mediated down-regulation of DNA binding activity of human FOXP3 are potentially involved in Treg cell instability. 48, 49 With the loss of Foxp3 expression, Treg cells usually lose their suppressive function and obtain partial phenotypes and functions of effector Th cells, such as the production of IFN-c and IL-17. Given the crucial roles of Treg cells in immune balance, the instability of Treg cells, especially in local tissues, such as pancreas islets, disturbs the immune balance and unleashes a local pathogenic T-cell response. In addition, the effector Th cell-like functions of 'exTreg' cells also directly contribute to the pathogenic immune response in local tissues.
Self-skewed TCR repertoire. The TCR endows T cells with high specificity to recognize diverse antigens, and TCR stimulation by antigens leads to T-cell activation in the presence of co-stimulatory signals in the periphery. In the central tolerance process, thymocytes harboring autoreactive TCRs are subjected to apoptosis during negative selection in the thymus, whereas those with proper TCR specificity and affinity survive and mature into T cells, including Treg cells and naive T cells. However, there are differences between the TCR properties of Treg cells and naive T cells, as demonstrated by evidence from TCR repertoire sequencing, TCR transgenic mice, and cell lines, which suggest that high-affinity TCRs below the threshold required for negative selection favor the development of Treg cells in the thymus, resulting in a TCR repertoire that is biased toward self-antigens in Treg cells. [50] [51] [52] [53] 54 showed that tumor-recruited Treg cells expressed vascular endothelial growth factor A, which directly contributed to tumor angiogenesis. Similarly, Tan et al. 55 reported that tumor-infiltrating Treg cells expressed RANKL, which stimulated the metastatic progression of RANK-expressing breast/mammary carcinoma cells. Moreover, Blatner et al. 56 described a Treg cell subset marked by the expression of RORct in human colon cancer and a mouse model of hereditary polyposis. These RORct 
PATHOGENIC EXTREG CELLS AND DISEASES
Consistent with the potential pathogenicity of Treg cells discussed above, many studies have proved that Treg cells indeed turn pathogenic in several disease models. In most cases reported to date, the pathogenic conversion of Treg cells is associated with an instability of Foxp3 expression. According to Koch's postulates, 57 bacteria that are sufficient to introduce disease in a healthy organism are recognized as pathogenic bacteria. Similarly, to define the pathogenicity of exTreg cells, it should be clear whether these cells are able to transfer diseases when they are introduced into a healthy host. Because lymphocytes can be easily transferred into a new host through intravenous injection, most studies are based on adoptive transfer experiments in lymphodeficient mice (Table 1) .
Foxp3-GFP KI reporter mice harbor GFP-labeled Treg cells expressing a chimeric GFP-Foxp3 fusion protein, 21 which helps to obtain Treg cells with high-purity. Using this mice strain, Zheng et al. 58, 59 showed that nTreg cells are converted to Th17 cells by IL-6 treatment in vitro. To study the Treg cell stability in vivo, Duarte et al. 60 T cells do not represent the naturally generated exTreg cells in vivo because their generation is primarily due to insufficient IL-2 in recipient mice. 60 To trace Treg cells in vivo, we generated another Foxp3 reporter mouse strain that carries Foxp3 BAC-driven GFPCre. In this strain, the GFP signal indicates transcription of the Foxp3 gene with high fidelity. 61 These mice were crossed to Rosa26-loxp-stop-loxp-YFP mice 62 to generate Foxp3-GFPCre3R26-YFP mice in which the GFP-Cre 1 cells were permanently marked by YFP due to the removal of the floxed-stop cassette by the GFP-Cre activity. Thus, Foxp3-GFP-Cre3R26-YFP mice provide a valuable model to monitor Foxp3 expression in traceable Treg cells at the single-cell level. Using this model, we found that considerable exTreg cells existed in the periphery in vivo under both homeostatic and autoimmune conditions. These exTreg cells resembled activated/memory T cells in respect to their phenotypes and their ability to produce inflammatory cytokines. To further investigate the function of these exTreg cells, we sorted exFoxp3 cells, conventional T cells, and Treg cells from Foxp3-GFP-Cre3R26-YFP BDC2.5 mice (BDC2.5 TCR-transgenic CD4
1 T cells recognize a pancreatic islet autoantigen), and transferred each population into NOD Rag2 2/2 mice after expansion in vitro. We observed that mice receiving Treg cells had normal blood glucose concentrations, whereas those receiving exFoxp3 cells and conventional T cells rapidly displayed islet destruction and developed diabetes. 34 Our study describes exTreg cells physiologically generated in vivo and proves that such natural exTreg cells are pathogenic. The exFoxp3 cell expressing BDC2.5 TCR specifically damages pancreatic islet, consistent with the concerns about the skewed self-reactive TCR repertoire of exTreg cells.
Similarly, the pathogenicity of exTreg cells is also evident in an experimental autoimmune encephalitis (EAE) model. 45 In this study, Bailey-Bucktrout et al. 45 induced EAE disease in Foxp3-GFP-Cre3R26-RFP mice using MOG 1 T cell-derived Th17 cells alone did not induce osteoclastogenesis. 64 To study the pathogenicity of unstable Treg cells in arthritis, CD25 
CD4
1 T cells did not exacerbate arthritis symptoms, indicating that the pathogenicity of exTreg cells in the collagen-induced arthritis model depended on their TCR specificity to type II collagen.
Human Treg cells are more likely easy to convert to Th17 cells by IL-1b and IL-2 treatment in vitro.
65, 66 Bovenschen 72 Similarly, CNS2-deficient Treg cells readily lose Foxp3 expression and convert to IFN-c-and IL-17-producing effector T cells under inflammatory conditions, which contributes to the autoimmune disease in CNS2-deficient mice. 42, 43 Taken together, these studies based on adoptive transfer experiments directly prove the pathogenicity of exTreg cells in vivo. It appears that both self-reactive TCR and effector Th cell-like functions are required for the pathogenic role of exTreg cells. It is possible that autoreactivity directs the activation and accumulation of exTreg cells in target tissues, and effector T helper cell-like functions of exTreg cells promote pathogenic immune responses.
EXTREG CELLS PARTICIPATE IN A FEED-FORWARD LOOP IN THE PATHOGENESIS OF AUTOIMMUNE DISEASES
Autoimmune diseases occur when self-antigens are targeted by the adaptive immune response. These self-antigens cannot be cleared, which leads to sustained autoimmune responses and tissue damage, such as pancreatic b-cell destruction in type 1 diabetes, joint inflammation in rheumatoid arthritis, and central nervous system tissue damage in human multiple sclerosis. The damaged tissues are usually infiltrated with diverse stromal and immune cells, pro-inflammatory cytokines, chemokines and exposed self-antigens, which constitute complex pathological microenvironments where the immune balance is skewed toward inflammation. Based on the pathogenicity of exTreg cells in autoimmune diseases, we propose a feed-forward model to understand the pathogenesis of autoimmune diseases.
First, the exposed self-antigens and pro-inflammatory cytokines in damaged tissues continually activate effector Th cellmediated immune responses, which in turn attack the selftissues, resulting in more self-antigen exposure and production of pro-inflammatory cytokines in situ. Second, self-antigens and proinflammatory cytokines in damaged tissues promote the instability of local Treg cells, and unstable Treg cells turn pathogenic for the self-tissues, resulting in more severe damage. Third, the generation of exTreg cells favors the activation and expansion of autoreactive effector Th cells, on the other hand, activated effector Th cells promote the generation and effector Th-like function of exTreg cells by Th-producing cytokines (e.g., IL-4 and IL-6 42 ). In addition, it is possible that activated Th cells become more resistant to the suppression of Treg cells. Fourth, these feed-forward loops promote each other and constitute a higher-level feed-forward loop to drive the development of autoimmune diseases (Figure 1 ). treating cancers. One paradox for such strategies is that drastic reduction of Treg cell immunoregulation may lead to autoimmunity. Thus, to elicit anti-tumor immunity without causing autoimmune disorders, modifying functions or stability of Treg cells is more optimal than systemically deleting Treg cells. To date, agonistic antibodies targeting CD25, GITR, CTLA-4, OX40 and FR4 have been reported to be useful for inhibiting the suppressive function of Treg cells and beneficial for antitumor immunity. [73] [74] [75] [76] [77] Apart from antibodies blocking the key functional molecules of Treg cells, chemical drugs that selectively impede Treg cell function or stability are also attractive. C646, a small-molecule nonpeptidic inhibitor of p300 (p300i), destabilizes Foxp3 expression and impairs nTreg suppressive function; importantly, C646 treatment boosts anti-tumor immunity. 78 Given that strong COT/Tpl2-MEK1 and PI(3)K signaling destabilizes Treg cells, 44, 46, 47 approaches that specifically augment these signaling pathways should be helpful for inhibiting the immunoregulation of Treg cells and favoring anti-tumor immunity.
GENERATION OF EXTREG CELLS FAVORS ANTI-TUMOR IMMUNITY

CONCLUSIONS
Although adoptive transfer experiments provide evidence for the pathogenicity of exTreg cells, it should be noted that lymphodeficient recipient mice and superabundant transferred exTreg cells may artificially exaggerate their pathogenicity. Nevertheless, studies using different disease models clearly show that Treg cells can become pathogenic. Such pathogenic conversion of Treg cells usually occurs in pathological environments, which implies a feedback mechanism between pathogenic conversion of Treg cells and diseases. Importantly, some findings provide valuable indications for solving this problem. For example, IL-2/IL-2 mAb complex and all-trans retinoic acid not only promote the expansion of Treg cells but also help to sustain the stable Foxp3 expression in Treg cells. 45, 79, 80 Finally, pathogenic conversion of Treg cells is closely related to diseases caused by local tissue disorders so it is important to study Treg cells that reside in local pathological tissues rather than total Treg cells. More precise studies are needed to illustrate the roles of pathogenic conversion of Treg cells in diseases, which will aid in the development of medicines and therapies that target such pathogenically converted Treg cells.
